High rates of fatty acid (FA) mobilization from adipose tissue are associated with insulin resistance (IR) in obesity. In vitro evidence suggests that iron stimulates lipolysis in adipocytes, but whether iron is related to in vivo FA mobilization is unknown. We hypothesized that plasma ferritin concentration ([ferritin]), a marker of body iron stores, would be positively associated with FA mobilization. We measured [ferritin], the rate of appearance of FA in the systemic circulation (FA Ra; stable isotope dilution), key adipose tissue lipolytic proteins and IR (hyperinsulinaemiceuglycaemic clamp) in 20 obese, premenopausal women. [Ferritin] was correlated with FA Ra (r = 0.65; P = 0.002) and IR (r = 0.57; P = 0.008); these relationships remained significant after controlling for body mass index and plasma [C-reactive protein] (a marker of systemic inflammation) in multiple regression analyses. We then stratified subjects into tertiles based on
INTRODUCTION
Accumulating evidence suggests that dysregulated iron homeostasis contributes to metabolic dysfunction in obesity (Gabrielsen et al., 2012; Moreno-Navarrete et al., 2014; Orr et al. 2014) , but the mechanisms linking iron and metabolic health remain incompletely understood (Fernández-Real, McClain, & Manco, 2015) . High rates of adipose tissue lipolysis and fatty acid (FA) release into the systemic circulation are associated with insulin resistance in obesity (Van Pelt, Guth, Wang, & Horowitz, 2017) , and some ex vivo/in vitro evidence indicates that iron increases lipolysis in adipocytes (Chirumbolo et al., c 2018 The Authors. Experimental Physiology c 2018 The Physiological Society 2015; Rumberger, Peters, Burrington, & Green, 2004) . There is also some epidemiological evidence linking markers of iron metabolism with plasma FA concentrations (Wlazlo et al., 2013) , and it has been suggested that iron-mediated lipolysis and FA release might contribute to impaired insulin sensitivity in obesity (Chirumbolo et al., 2015; Rumberger et al., 2004; Wlazlo et al., 2013) . However, the relationship between iron and in vivo FA release has not been examined. The purpose of this study was to determine whether plasma ferritin concentration ([ferritin] ), a marker of total body iron stores (Worwood, 2007) , is positively associated with elevated rates of FA release from adipose tissue in obese, premenopausal women.
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METHODS

Ethical approval
This study was part of a larger investigation of the relationship between FA mobilization and insulin resistance in obese adults. Some of the methods for this study have been reported elsewhere (Van Pelt et al., 2017) but are briefly repeated here for convenience.
All findings reported in this paper are new. This study conformed to the standards set by the latest version of the Declaration of Helsinki, was registered at clinicaltrials.gov (NCT01452048) and was approved by the University of Michigan Institutional Review Board (HUM00051537). All participants provided written, informed consent.
Experimental protocol
We studied 20 obese, premenopausal women with plasma [ferritin] within the clinically normal range (12-200 ng ml −1 ; Worwood, 2007) .
Participants were weight stable for ≥6 months, not pregnant or breastfeeding and not taking medications/supplements known to affect their metabolism. Participants were studied after an overnight fast during the follicular phase of their menstrual cycle. We collected a baseline blood sample and a subcutaneous abdominal adipose tissue sample, under local anaesthetic (Van Pelt et al., 2017) . The rate of appearance of FA in the systemic circulation (FA Ra) was assessed using 13 C-palmitate isotope dilution as detailed elsewhere (Van Pelt et al., 2017) . Briefly, after collecting the baseline blood and adipose tissue samples, 13 C-palmitate was infused at a rate of 0.04 mol kg −1 min −1 for 1 h. After 45 min, we collected three blood samples separated by 5 min for the determination of the tracer-to-tracee ratio (TTR) of 13 C/ 12 C-palmitate in plasma for subsequent FA Ra calculations (Patterson, Zhao, & Klein, 1998) . Insulin resistance was assessed using a 2 h primed, hyperinsulinaemic-euglycaemic clamp; insulin was infused at a rate of 100 mU m −2 min −1 , and insulin sensitivity (the inverse of insulin resistance) was determined as the steady-state glucose infusion rate at the end of the clamp period divided by fat-free mass (assessed via dual-energy X-ray absorptiometry). 
Analytical methods
Statistics
All data are presented as means ± SD. 
RESULTS
Plasma [ferritin] and group stratification
Plasma [ferritin] in our subjects ranged from 23 to 197 ng ml −1 , which is within the clinically normal range (Worwood, 2007) . We stratified subjects into tertiles for comparisons between subjects with TA B L E 1 Anthropometric and clinical measures in the Low-ferritin versus High-ferritin group Parameter Low-ferritin (n = 6) High-ferritin (n = 6) P value 
Fatty acid mobilization
Fatty acid rate of appearance (in micromoles per kilogram of fat mass per minute) was >80% greater in the High-ferritin versus Low-ferritin group (P = 0.02; Figure 1a) . The large between-group difference in FA Ra remained significant when expressed in absolute terms (696 ± 191 versus 413 ± 133 mol min −1 , P = 0.01) or normalized to fat-free mass (13.7 ± 3.6 versus 8.6 ± 2.0 mol kg −1 min −1 , P = 0.01). Accompanying the greater FA Ra in the High-ferritin versus Low-ferritin group, total protein abundance of HSL and ATGL and the ratio of p-HSL ser660 to HSL (a marker of elevated lipolytic activation) were all significantly greater in the High-ferritin group (P < 0.05; Figure 1b ). There were no differences in the ratio of p-ATGL ser406 to ATGL (Figure 1b) . Across all 20 subjects, plasma
[ferritin] was significantly correlated with FA Ra (r = 0.65; P = 0.002; Figure 1c ). Importantly, using multiple regression analyses, plasma 
Insulin sensitivity
Whole-body insulin sensitivity was nearly 40% lower in the Highferritin versus Low-ferritin group (P = 0.02; Figure 1d 
DISCUSSION
The major new finding of this study was that plasma [ferritin] was linked with elevated FA Ra in obese, premenopausal women. The mechanisms linking iron and insulin resistance remain incompletely understood, but our findings suggest that iron-mediated FA mobilization might be a key underlying mechanism. Previous studies reported that ex vivo and in vitro treatment of murine adipocytes with iron increased glycerol release (Chirumbolo et al., 2015; Rumberger et al., 2004) , suggesting the possibility that iron might directly or indirectly activate ATGL and/or HSL, the two primary enzymes catalysing triglyceride hydrolysis (i.e. lipolysis). Gene expression of HSL was recently reported to be significantly increased (and the increase in ATGL expression was almost statistically significant) in mice after 4 weeks of dietary iron supplementation (Katsumura et al., 2017 ), but to our knowledge, the influence of iron on lipase protein activation/abundance has not been examined previously. Our findings that total protein abundance of both HSL and ATGL and the ratio of p-HSL ser660 to HSL were significantly greater in the High-ferritin versus Low-ferritin group suggest that iron might increase lipase protein abundance and activation. Iron is a potent inducer of reactive oxygen species, which have been found to increase adipocyte HSL activation in vitro (Krawczyk, Haller, Ferrante, Zoeller, & Corkey, 2012) .
Based on these findings, our working hypothesis is that elevated iron increases reactive oxygen species signalling, thereby increasing lipase activity and FA Ra, resulting in impaired insulin sensitivity.
Our cross-sectional study design enabled us to compare obese subjects with widely differing iron stores who were otherwise well matched. We hypothesize that iron stimulates lipolysis, resulting in elevated FA Ra, but we cannot rule out the possibility that the converse is true (i.e. elevated FA Ra might increase iron uptake and storage) or warranted to determine whether lowering iron stores is a potential
